Henrik Toft Sørensen is professor of clinical epidemiology, and is founder and chair of Department of Clinical Epidemiology at Aarhus University Hospital, which was established in 2000. He is a physician and specialist in internal medicine and hepatology, has trained at several major Danish hospitals and acted as a clinician until 2005. He has been affiliated with Boston University since 2005.
Dr. Sørensen has more than 25 years of experience in clinical and epidemiological research. His research covers, among others, pharmacoepidemiology, epidemiological methods and determinants of the prognosis of several chronic diseases. Dr. Sørensen is author or co-author of more than 1,400 publications and has been supervisor for more than 60 doctoral students. He is Editor in Chief of Clinical Epidemiology.
Aarhus University Hospital
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 1421 results.
Ahern TP, Spector LG, Damkier P, Öztürk Esen B, Ulrichsen SP, Eriksen K, Lash TL, Sørensen HT, Cronin-Fenton DP. Medication-Associated Phthalate Exposure and Childhood Cancer Incidence. J Natl Cancer Inst. 2022 Jun 13; 114(6):885-894. PMID: 35179607
Dudukina E, Horváth-Puhó E, Sørensen HT, Ehrenstein V. Correction to: Long-term risk of epilepsy, cerebral palsy and attention-deficit/hyperactivity disorder in children affected by a threatened abortion in utero. Int J Epidemiol. 2022 Jun 13; 51(3):1034. PMID: 35437592
Johannesdottir Schmidt SA, Veres K, Sørensen HT, Obel N, Henderson VW. Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study. Neurology. 2022 Jun 08. PMID: 35676090
Olesen KKW, Jensen ES, Gyldenkerne C, Würtz M, Mortensen MB, Nørgaard BL, Sørensen HT, Bøtker HE, Maeng M. Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome. Eur Heart J Qual Care Clin Outcomes. 2022 06 06; 8(4):437-446. PMID: 33629103
Mortensen MB, Dzaye O, Razavi AC, Jensen JM, Steffensen FH, Bøtker HE, Cainzos-Achirica M, Sørensen HT, Maeng M, Blaha MJ, Nasir K, Nørgaard BL. Association between REDUCE-IT criteria, coronary artery disease severity and cardiovascular events: The Western Denmark Heart Registry. Eur J Prev Cardiol. 2022 Jun 03. PMID: 35653637
Foverskov E, White JS, Norredam M, Frøslev T, Kim MH, Glymour MM, Pedersen L, Sørensen HT, Hamad R. Neighbourhood socioeconomic disadvantage and psychiatric disorders among refugees: a population-based, quasi-experimental study in Denmark. Soc Psychiatry Psychiatr Epidemiol. 2022 May 21. PMID: 35597890
Gaster N, Pedersen L, Ehrenstein V, Böttcher M, Bøtker HE, Sørensen HT, Schmidt M. Cardiovascular risks associated with use of non-steroidal anti-inflammatory drugs in patients with non-obstructive coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2022 May 05; 8(3):282-290. PMID: 34864969
Jørgensen H, Horváth-Puhó E, Laugesen K, Brækkan S, Hansen JB, Sørensen HT. TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism. Thromb Res. 2022 May; 213 Suppl 2:S18-S19. PMID: 35643655
Troelsen FS, Vágó EK, Horváth-Puhó E, van Es N, Mulder FI, Moik F, Erichsen R, Ay C, Sørensen HT. TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study. Thromb Res. 2022 May; 213 Suppl 2:S11. PMID: 35643641
Skajaa N, Veres K, Troelsen FS, Petersen JD, Adelborg K, Sørensen HT. TEMPORARY REMOVAL: OC-12: Stroke and risk of cancer: a Danish population-based cohort study. Thromb Res. 2022 May; 213 Suppl 2:S7. PMID: 35643713